Bruker (BRKR) Cash & Current Investments (2009 - 2026)

Bruker (BRKR) has 18 years of Cash & Current Investments data on file, last reported at $161.6 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Current Investments fell 15.88% year-over-year to $161.6 million; the trailing twelve-month figure through Mar 2026 stood at $161.6 million (down 15.88% YoY), and the FY2025 full-year result was $322.6 million, up 68.9% from the prior year.
• Cash & Current Investments for Q1 2026 stood at $161.6 million, down from $322.6 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $916.1 million in Q1 2022 and bottomed at $124.8 million in Q2 2025.
• The 5-year median for Cash & Current Investments is $363.6 million (2023), against an average of $412.0 million.
• The widest annual swing landed in 2024, when Cash & Current Investments tumbled 64.89%; it then jumped 68.9% in 2025.
• A 5-year view of Cash & Current Investments shows it stood at $660.3 million in 2022, then fell by 24.23% to $500.3 million in 2023, then slumped by 61.82% to $191.0 million in 2024, then surged by 68.9% to $322.6 million in 2025, then plunged by 49.91% to $161.6 million in 2026.
• The last three Cash & Current Investments figures came in at $161.6 million (Q1 2026), $322.6 million (Q4 2025), and $297.0 million (Q3 2025), per Business Quant data.

Peer Comparison